Learn about Candidiasis of the Skin (Cutaneous Candidiasis), including clinical documentation, medical coding, and treatment for Candidal Intertrigo. Find information on diagnosis, symptoms, and management of yeast infection of the skin for healthcare professionals.
Also known as
Candidiasis of skin and nails
Fungal skin infection caused by Candida species.
Other superficial candidiasis
Candidiasis affecting skin or mucous membranes not otherwise specified.
Dermatitis, unspecified
General term for inflammation of the skin, including possible candidal intertrigo.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the candidiasis intertriginous?
Yes
Code B37.1 Intertrigo candidal
No
Is there vulvovaginal involvement?
When to use each related code
| Description |
|---|
| Yeast skin infection. |
| Fungal skin infection. |
| Bacterial skin infection. |
Coding cutaneous candidiasis without specifying the affected body area can lead to claim rejection for lack of specificity. Use B37 codes with appropriate laterality and site.
Intertrigo, a common form of cutaneous candidiasis, may be overlooked. Accurate documentation and coding (L30.4) are crucial for appropriate reimbursement.
Failing to document and code underlying conditions like diabetes that predispose to candidiasis can impact risk adjustment and quality metrics.
Q: How can I differentiate between intertriginous candidiasis and other intertrigo types like bacterial or irritant dermatitis in clinical practice?
A: Differentiating intertriginous candidiasis from other forms of intertrigo requires a careful assessment of clinical features and sometimes confirmatory testing. Candidal intertrigo typically presents as erythematous plaques with well-defined, scalloped borders, often accompanied by satellite papules and pustules. A key feature is the presence of maceration in skin folds, which can be exacerbated by moisture and friction. While bacterial intertrigo can also present with erythema and maceration, it may involve a foul odor and less distinct borders. Irritant dermatitis in intertriginous areas lacks satellite lesions and may appear more diffuse, with a history suggestive of friction or chemical exposure. KOH microscopy can confirm the presence of yeast in candidal intertrigo, providing a definitive diagnosis. Consider implementing a combination of clinical evaluation and KOH microscopy to accurately differentiate between these conditions. Explore how different diagnostic tools can assist in identifying various dermatological issues.
Q: What are the most effective topical antifungal treatments for cutaneous candidiasis in immunocompetent adults, considering both efficacy and patient adherence?
A: Several topical antifungal agents demonstrate efficacy against cutaneous candidiasis in immunocompetent adults. Azoles, such as clotrimazole, miconazole, and ketoconazole, are generally considered first-line treatment options. These agents are available in various formulations, including creams, lotions, and powders. Allylamines, like terbinafine and naftifine, also offer effective treatment, particularly for areas with hair involvement. When selecting a topical antifungal, consider patient adherence factors like application frequency and formulation preference. For example, once-daily application may improve compliance compared to multiple daily applications. Additionally, certain formulations may be more suitable for specific body areas. Creams are generally well-tolerated in most areas, while lotions may be preferred for hairy areas and powders for intertriginous folds. Learn more about individual patient considerations for optimal antifungal therapy selection and improved treatment outcomes.
Patient presents with clinical manifestations consistent with cutaneous candidiasis, also known as candidal intertrigo or yeast infection of the skin. Affected areas include [specify location, e.g., intertriginous folds of the groin, axillae, inframammary folds, or other affected skin areas]. The patient reports [symptoms, e.g., pruritus, burning sensation, erythema, satellite lesions, maceration]. Physical examination reveals [objective findings, e.g., erythematous plaques with well-defined borders, scaling, pustules, or other relevant clinical features]. Differential diagnosis includes intertrigo, seborrheic dermatitis, and psoriasis. Diagnosis of candidiasis is based on clinical presentation and may be confirmed with potassium hydroxide (KOH) preparation showing pseudohyphae and budding yeast. Treatment plan includes topical antifungal therapy with [specify medication, e.g., clotrimazole, miconazole, ketoconazole] applied to the affected area [frequency] for [duration]. Patient education provided on proper hygiene practices, including keeping the affected area clean and dry, and avoiding tight-fitting clothing. Follow-up appointment scheduled in [timeframe] to assess treatment response and adjust management as needed. ICD-10 code B37.2 (Candidiasis of skin and nails) is applicable. This documentation supports medical necessity for the prescribed treatment.